For the 2022 Paediatric Urology Guidelines, 3 chapters of the Guidelines have been updated through a structured assessment of the literature and these additional references and text updates have been incorporated. A new section on Eosinophilic cystitis and Nephrogenic adenoma has been added to the chapter on bladder tumours.
Key changes in the 2022 publication:
- Section 3.11 - Monosymptomatic nocturnal enuresis – bedwetting: Both the literature and the text have been extensively updated;
- Section 3.12 - Management of neurogenic bladder: Both the literature and the text have been updated;
- Section 3.16 - Obstructive pathology of renal duplication: ureterocele and ectopic ureter: The literature has been updated resulting in minor amendments to the text;
- Section 3.19 – Rare Conditions – A new section has been added to the section on bladder tumours on eosinophilic cystitis and nephrogenic adenoma.
New recommendations
3.19 Recommendations for rare conditions in children
3.19.2.9 Recommendations for papillary tumours of the bladder in children
Recommendations | LE | Strength rating |
Have a high index of suspicion of eosinophilic cystitis (EC) in protracted urinary tract symptoms unresponsive to regular treatment. | 4 | Strong
|
Any possible allergens as the obvious first step in managing EC. | 4 | Strong |
Eosinophilic cystitis can be managed medically with corticosteroids, antibiotics, anticholinergics, and antihistamines, in addition to cyclosporine A. | 4 | Weak
|
Manage nephrogenic adenoma (NE) by resection either transuretherally or by open excision. | 4 | Strong
|
Regular endoscopic follow-up especially for augmented patients with NA is justified. | 4 | Weak |